首页 | 本学科首页   官方微博 | 高级检索  
检索        


Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis,treatment and follow-up
Institution:1. Department of Pulmonology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands;2. Aberdeen Royal Infirmary, Aberdeen University Medical School, Aberdeen, UK;3. Medical Oncology Department, University and Hospital Trust of Verona, Verona, Italy;4. Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China;5. Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany;6. Department of Radiation Oncology, Kliniken Maria Hilf, Moenchengladbach, Germany;7. Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy;8. Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland;9. Department of Medical Oncology, Thoracic Group, Gustave-Roussy Villejuif, France;10. Thoracic Oncology Service, Netherlands Cancer Institute, Amsterdam, the Netherlands;11. Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands;12. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia;13. Faculty of Medicine and Surgery-Vita-Salute San Raffaele University, Milan, Italy;14. Division of Thoracic Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy;15. Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, Lung Clinic, Grosshansdorf, Germany
Abstract:
Keywords:ESCAT  ESMO Clinical Practice Guideline (CPG)  ESMO-MCBS  oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC)  treatment  targeted therapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号